The stock surge is attributed to positive earnings and leadership change, which are typically seen as favorable by investors. The political shift is also perceived as beneficial for CVS, potentially impacting future policy and market conditions. However, ongoing challenges like high medical costs and restructuring charges could affect future earnings.